ArticleScientific reports2025
Antimalarial activity of root extract of Tephrosia villosa L. Pers. (Fabaceae) on Plasmodium berghei-infected mice.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Exploring the antimalarial potential of (+)-2,2'-epicytoskyrin A: in vitro and in vivo studies of a bioactive metabolite from endophytic fungus Diaporthe sp. GNBP-10.Malaria journal · 2026Article
- Antitumor-Directed Fractionation ofPharmaceuticals (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Scientists are urged to discover new drugs since treatment resistance makes malaria hard to control. One important source of new drugs is medicinal plants. The antimalarial qualities of Tephrosia villosa roots in vitro demonstrated its good effect to treat malaria infections. On the other hand, its effect in vivo is unknown. This study filled the gap by evaluating the antimalarial effectiveness of Tephrosia villosa's Dichloromethane/methanol (1:1) extract against Plasmodium berghei infection in a mouse model.Dichloromethane/methanol (1:1) was used to extract the dried, powdered roots of Tephrosia villosa, and the extract's safety profile was assessed using an acute toxicity test. By giving 100, 200, and 400 mg/kg dosages of the extract, the antimalarial activity of the extract was assessed by the 4-day suppressive, Rane's, and prophylactic tests. To establish the activity, criteria such as body weight, packed cell capacity, temperature, survival time, and parasitemia level were measured.According to the acute oral toxicity result, the extract caused no signs of toxicity in mice in 24 h and within 14 days of observation. It was proven to have chemosuppressive, curative, and prophylactic activities. It has decreased the level of parasitemia and improved mean survival time in parasite infected mice in used models. The extract at 400 mg/kg dose suppressed parasitemia by 24.78%, 52.16%, and 49.09% in 4-day suppressive, curative and prophylactic test models (p < 0.001) respectively. Moreover, it inhibited reduction in packed cell volume, body weight, and temperature fall in all tested models as compared to the negative control. The findings revealed that the extract of the plant was safe at 2 g/kg dose on acute oral toxicity test and was proven to have antimalarial effect for plasmodium berghei infection in mice which supports the in vitro test.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.